Washington University Podcasts Washington University RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

The Three Levels of Smoking Cessation
Laura Jean Bierut, MD of Washington University of Medicine discusses the three levels of smoking cessation from the 22nd Annual Perspectives in Thoracic Oncology in New York <a target='_blank' href='http://imedex.com/perspect'>http://imedex.com/perspect...</a>... Author: thoraciconcology Added: 12/27/2017 (Source: Oncology Tube)
Source: Oncology Tube - December 27, 2017 Category: Cancer & Oncology Source Type: podcasts

E-Cigarettes Better Than Combustible Cigarettes
Laura Jean Bierut, MD of Washington University of Medicine discusses the benefits of E-Cigarettes over combustible cigarettes from the 22nd Annual Perspectives in Thoracic Oncology in New York http://... Author: thoraciconcology Added: 12/27/2017 (Source: Oncology Tube)
Source: Oncology Tube - December 27, 2017 Category: Cancer & Oncology Source Type: podcasts

E-Cigarettes May Be The Greatest Public Health Benefit This Century
Laura Jean Bierut, MD of Washington University of Medicine talks about E-Cigarettes and how they may be the greatest public health benefit this century from the 22nd Annual Perspectives in Thoracic On... Author: thoraciconcology Added: 12/27/2017 (Source: Oncology Tube)
Source: Oncology Tube - December 27, 2017 Category: Cancer & Oncology Source Type: podcasts

Two Main Nicotine Responders Genetic Variations and Metabolic Enzymes
Laura Jean Bierut, MD of Washington University of Medicine discusses the two main nicotine responders genetic variations and metabolic enzymes from the 22nd Annual Perspectives in Thoracic Oncology in... Author: thoraciconcology Added: 12/27/2017 (Source: Oncology Tube)
Source: Oncology Tube - December 27, 2017 Category: Cancer & Oncology Source Type: podcasts

440,000 vs 60,000 fatalities per year Lung Cancer vs Opioid Crisis
Laura Jean Bierut, MD of Washington University of Medicine discusses 440,000 vs 60,000 fatalities per year Lung Cancer vs Opioid Crisis at the 22nd Annual Perspectives in Thoracic Oncology in New York... Author: thoraciconcology Added: 12/27/2017 (Source: Oncology Tube)
Source: Oncology Tube - December 27, 2017 Category: Cancer & Oncology Source Type: podcasts

When To Focus on Smoking Cessation
Laura Jean Bierut, MD of Washington University of Medicine talks about When To Focus on Smoking Cessation from the 22nd Annual Perspectives in Thoracic Oncology in New York <a target='_blank' href='http://imedex.com/perspecti'>http://imedex.com/perspecti...</a>... Author: thoraciconcology Added: 12/26/2017 (Source: Oncology Tube)
Source: Oncology Tube - December 26, 2017 Category: Cancer & Oncology Source Type: podcasts

Improving existing imaging technology for multiple myeloma
The current baseline imaging technology for multiple myeloma (MM) management includes PET and MRI. In this interview, Ravi Vij, MD, MBA, from the Washington University School of Medicine, St Louis, WA... Author: VJHemOnc Added: 12/07/2017 (Source: Oncology Tube)
Source: Oncology Tube - December 7, 2017 Category: Cancer & Oncology Source Type: podcasts

Improving existing imaging technology for multiple myeloma
The current baseline imaging technology for multiple myeloma (MM) management includes PET and MRI. In this interview, Ravi Vij, MD, MBA, from the Washington University School of Medicine, St Louis, WA... Author: VJHemOnc Added: 11/29/2017 (Source: Oncology Tube)
Source: Oncology Tube - November 29, 2017 Category: Cancer & Oncology Source Type: podcasts

When to use bispecifics for AML
As alternatives to chemotherapy are created, the prospect of having treatments with a lower toxicity becomes more tangible. In this video, Prof. John DiPersio, MD, PhD from Washington University Schoo... Author: VJHemOnc Added: 11/24/2017 (Source: Oncology Tube)
Source: Oncology Tube - November 24, 2017 Category: Cancer & Oncology Source Type: podcasts

Expanding trials using bispecifics
This is an exciting time for leukemia research, with the latest research using bispecifics revealing positive outcomes for patients. Here, Prof. John DiPersio, MD, PhD of Washington University School ... Author: VJHemOnc Added: 11/23/2017 (Source: Oncology Tube)
Source: Oncology Tube - November 23, 2017 Category: Cancer & Oncology Source Type: podcasts

Cytokine release syndrome: a limiting factor for AML treatment
The inflammation induced by medication can create challenges when producing novel treatments. In this interview, Prof. John DiPersio, MD, PhD from Washington University School of Medicine, Washington,... Author: VJHemOnc Added: 11/23/2017 (Source: Oncology Tube)
Source: Oncology Tube - November 23, 2017 Category: Cancer & Oncology Source Type: podcasts

The problem of treating AML with CD123-targeting drugs
As diseases mutate our knowledge of them increases. In this interview, Prof. John DiPersio, MD, PhD from Washington University School of Medicine, Washington, WA explains how the low number of mutatio... Author: VJHemOnc Added: 11/23/2017 (Source: Oncology Tube)
Source: Oncology Tube - November 23, 2017 Category: Cancer & Oncology Source Type: podcasts

The role of epigenetic modulators in the pathogenesis of lymphomas
Anas Younes, MD, from the Memorial Sloan Kettering Cancer Center, New York, NY is joined by Eduardo Sotomayor, MD, from the George Washington University School of Medicine &amp; Health Sciences, Washi... Author: VJHemOnc Added: 11/20/2017 (Source: Oncology Tube)
Source: Oncology Tube - November 20, 2017 Category: Cancer & Oncology Source Type: podcasts

How are immunotherapies re-shaping the treatment of lymphoma
Catherine Bollard, MBChB, MD, FRACP, FRCPA from the Childrens National Health System and the George Washington University, Washington, D.C. chairs a lively discussion on the fast-evolving field of im... Author: VJHemOnc Added: 11/20/2017 (Source: Oncology Tube)
Source: Oncology Tube - November 20, 2017 Category: Cancer & Oncology Source Type: podcasts

Classify the Unclassified Renal Cell Carcinoma
James J. Hsieh MD of Siteman Cancer Center, Washington University discusses how to classify the unclassified renal cell carcinoma at the 2017 Kidney Cancer Association symposium in Miami, FL. <br /><br /> Author: kidneycancer Added: 11/07/2017 (Source: Oncology Tube)
Source: Oncology Tube - November 7, 2017 Category: Cancer & Oncology Source Type: podcasts